Related Experiment Video
Updated: Jun 12, 2026
07:54
Cholesterol Efflux Assay
Published on: March 6, 2012
Cholesteryl ester transfer protein and its inhibition
Olaf Weber1, Hilmar Bischoff, Carsten Schmeck
1Bayer Healthcare AG/Bayer Schering Pharma, 42096, Wuppertal, Germany. olaf.weber@bayerhealthcare.com
Cellular and Molecular Life Sciences : CMLS
|June 18, 2010
Summary
Cholesteryl ester transfer protein (CETP) moves lipids between lipoproteins, impacting heart disease risk. Inhibiting CETP for dyslipidemia treatment remains controversial due to conflicting study results.
Area of Science:
- Lipid metabolism
- Cardiovascular disease research
- Pharmacology
Background:
- Cholesteryl ester transfer protein (CETP) facilitates lipid transfer from HDL to LDL/VLDL.
- This process lowers HDL and raises LDL/VLDL, potentially influencing atherosclerosis.
- CETP inhibition is explored as a dyslipidemia treatment strategy.
Purpose of the Study:
- To review the molecular mechanisms of CETP activity.
- To discuss the controversies surrounding CETP inhibition in atherosclerosis.
- To provide an update on CETP inhibitors as therapeutic agents.
Main Methods:
- Literature review of CETP function and inhibition.
- Analysis of animal studies and clinical trial data.
- Discussion of molecular mechanisms and therapeutic perspectives.
Main Results:
- CETP activity influences lipoprotein profiles and atherosclerosis risk.
- Animal studies suggest benefits of CETP inhibition.
- Phase III trials with torcetrapib yielded negative clinical outcomes, raising concerns.
Conclusions:
- The role of CETP in atherosclerosis and the efficacy of its inhibition are debated.
- Despite potential benefits suggested by preclinical data, clinical translation faces challenges.
- Further research is needed to clarify CETP's complex role and therapeutic potential.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
01:22Cholinesterases: Distribution and Function
Cholinesterases are a group of serine hydrolase enzymes that play a crucial role in the breakdown of choline esters. The two primary types of cholinesterases are acetylcholinesterases (AChEs) and butyrylcholinesterase (BuChEs), which differ in their distribution, function, and substrate specificity. AChEs, also known as true cholinesterases, specifically hydrolyze acetylcholine, while BuChEs, often referred to as pseudocholinesterases, can hydrolyze various choline esters, including...
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
01:27Synthesis of Phosphatidylcholine in the ER Membrane
The ER synthesizes lipids for building cell membranes and performing cellular functions such as energy storage and signaling. The lipid synthesis machinery embedded in the ER membrane primarily collects all reactants from the cytosol. Following synthesis, the secretory pathway and the ER contact sites distribute these lipids to other cellular organelles. Additionally, the energy-rich triacylglycerides are transported from the ER via lipid droplets.
The major components of all eukaryotic cell...
The major components of all eukaryotic cell...